ZIOP ZIOPHARM Oncology, Inc.

[greencat]

ZIOP has moved up to resistance forming a cup pattern. It higly likely its going to make a bigger move.

ZIOP Chart



ZIOPHARM Oncology, Inc.
1180 Avenue of the Americas
Suite 1920
New York, NY 10036
United States - Map
Phone: 646-214-0700
Fax: 646-214-0711
Web Site: ZIOPHARM Oncology, Inc. | Welcome

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 14


BUSINESS SUMMARY
ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of a portfolio of cancer drugs in North America. Its products under various stages of development and trials include Palifosfamide for the treatment of sarcoma, lymphoma, testicular, and other cancers; Darinaparsin, a mitochondrial-targeted agent for the treatment of various hematologic and solid cancers; and Indibulin, an oral tubulin binding agent that targets mitosis and cancer cell migration. The company has license agreements with DEKK-Tec, Inc.; and Baxter Healthcare Corporation, as well as a collaboration agreement Harmon Hill, LLC. ZIOPHARM Oncology, Inc. was founded in 2003 and is headquartered in New York, New York.